The go-ahead for the vaccine developed by American drugmaker Pfizer and Germany’s BioNTech comes as the virus surges again in the United States and Europe, putting pressure on hospitals and morgues in some places and forcing new rounds of restrictions that have devastated economies.
The Medicines and Healthcare Products Regulatory Agency, which licenses drugs in the U.K., recommended the vaccine could be used after it reviewed the results of clinical trials that showed the vaccine was 95% effective overall — and that it also offered significant protection for older people, among those most at risk of dying from the disease. But the vaccine remains experimental while final testing is done.
“Help is on its way,” British Health Secretary Matt Hancock told the BBC, adding that the situation would start to improve in the spring.
“We now have a vaccine. We’re the first country in the world to have one formally clinically authorized but, between now and then, we’ve got to hold on, we’ve got to hold our resolve,” he said.
Other countries aren’t far behind: Regulators in the United States and the European Union also are vetting the Pfizer shot along with a similar vaccine made by competitor Moderna Inc. British regulators also are considering another shot made by AstraZeneca and Oxford University.
Hancock said Britain expects to begin receiving the first shipment of 800,000 doses “within days,” and people will begin receiving shots as soon as the National Health Service gets the vaccine.
Continue reading your story on the app
Continue reading your story in the magazine
Q&A: BITCOIN'S MASSIVE RISE AND WHAT COMES NEXT
The digital currency Bitcoin rocketed to a record high last week above $40,000 a coin.
VOLKSWAGEN TRIPLES ELECTRIC CAR SALES AHEAD OF CLIMATE RULES
Europe’s push into electric cars is gathering speed — despite the pandemic.
UK INVESTIGATES GOOGLE'S PLAN TO REVAMP CHROME BROWSER
Britain’s competition watchdog said it launched an investigation into Google’s plan to overhaul its ad data system over worries it could leave even less room for rivals in the online ad industry.
RACE ON: THE LINEUP FOR THE REVOLUTION OF THE CAR INDUSTRY
Wherever you are in the world, it’s hard to deny that 2020 was a challenging year - not least the automotive sector. With car sales plummeting amidst stay-at-home orders, consumers had a chance to reflect on their environmental impact, and as a result, electric vehicles are now more desirable than ever.
SOME UBER, LYFT DRIVERS SUE OVER CALIFORNIA BALLOT MEASURE
Drivers for app-based ride-hailing and delivery services filed a lawsuit to overturn a California ballot initiative that makes them independent contractors instead of employees eligible for benefits and job protections.
TARGET CONTINUES TO THRIVE IN WHIRLWIND RETAIL ENVIRONMENT
Target’s strong sales streak extended through a pandemic-shrouded holiday season after a hard push online and an increased effort to provide alternatives to customers who are trying to minimize risk.
TIKTOK TIGHTENS PRIVACY FEATURES FOR YOUNGER USERS
A month after federal regulators ordered it to disclose how its practices affect children and teenagers, TikTok is tightening its privacy practices for the under-18 crowd.
NEW MERCEDES SCREEN TO STRETCH NEARLY FULL WIDTH OF CAR
Daimler’s Mercedes-Benz has unveiled a key interior component of its upcoming electric luxury sedan: a large, curved screen that sweeps across almost the entire width of the car in the place of a conventional dashboard.
ELECTRIC TRUCK MAKER HITS 100,000 ORDERS AHEAD OF FALL START
An upstart electric vehicle maker said that it now has more than 100,000 orders for its new pickup truck.
CHINA'S GEELY, BAIDU ANNOUNCE ELECTRIC CAR VENTURES
Chinese automaker Geely says it will form an electric car venture with tech giant Baidu, adding to a flurry of corporate tie-ups in the industry to share soaring technology development costs.
HOW THE RICH & FAMOUS GET COVID VACCINE FIRST!
Money talks on thriving black market for life-saving shots
IN DEFENSE OF COVID BILLIONAIRES
PEOPLE LOVE TO hate billionaires. And they really love to hate large pharmaceutical companies.
Business at Its Best
With a big hand from the government, pharmaceutical companies delivered the vaccine that the world desperately needed. Here’s how something in 2020 went right for a change
The Window Is Closing On Vaccine Makers
With early leaders so effective, it may be tougher for laggards to conduct trials
NEW COVID VACCINES: WHAT YOU NEED TO KNOW!
Won’t work on 10% of the population! Two doses needed to be effective! Horrid side effects include pain, fatigue, headache & sore arms!
We Had the Vaccine the Whole Time
The silver bullet we’ve been waiting for took all of one weekend to design.
Finding Flights to Deliver Vaccines
The pandemic has vastly reduced airlines’ capacity to haul freight
PFIZER: COVID-19 SHOT 95% EFFECTIVE, SEEKING CLEARANCE SOON
Pfizer said this week that new test results show its coronavirus vaccine is 95% effective, is safe and also protects older people most at risk of dying — the last data needed to seek emergency use of limited shot supplies as the catastrophic outbreak worsens across the globe.
The Final Hurdle Is Bureaucracy
An alphabet soup of regulators raises the prospect of vaccine chaos
A Covid Boost for Flu Fighters
Developers of influenza vaccines are benefiting from the focus on the coronavirus